Cytokine-like 1 is involved in the growth and metastasis of neuroblastoma cells

International Journal of Oncology

Volumn 41, Issue 4, 2012, Pages 1419-1424

  Wen, Mingjie ^a   Wang, Huanmin ^b   Zhang, Xulong ^a   Long, Jun ^a   Lv, Zhe ^a   Kong, Qingli ^a   An, Yunqing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine like 1; Growth; Metastasis; Neuroblastoma; SiRNA

Indexed keywords

CYTOKINE; CYTOKINE LIKE 1; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEUROBLASTOMA; RECEPTORS, CYTOKINE; RNA, SMALL INTERFERING;

EID: 84866522940     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1552     Document Type: Article

References (31)

1. McHugh K: Renal and adrenal tumours in children. Cancer Imaging 7: 41-51, 2007.
2. Zhu H, Zheng J, Xiao X, et al: Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells. Oncol Rep 23: 129-139, 2010.
3. Rha SE, Byun JY, Jung SE, Chun HJ, Lee HG and Lee JM: Neurogenic tumors in the abdomen: tumor types and imaging characteristics. Radiographics 23: 29-43, 2003.
4. Pistoia V, Bianchi G, Borgonovo G and Raffaghello L: Cytokines in neuroblastoma: from pathogenesis to treatment. Immunotherapy 3: 895-907, 2011.
5. Metelitsa LS, Wu HW, Wang H, et al: Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J Exp Med 199: 1213-1221, 2004.
6. Zhang L, Yeger H, Das B, Irwin MS and Baruchel S: Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma. Neoplasia 9: 36-46, 2007.
7. Zeng Y, Huebener N, Fest S, et al: Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells. Cancer Res 67: 2331-2338, 2007.
8. Raffaghello L, Cocco C, Corrias MV, Airoldi I and Pistoia V: Chemokines in neuroectodermal tumour progression and metastasis. Semin Cancer Biol 19: 97-102, 2009.
9. + cells. Genomics 65: 283-292, 2000.
10. Hermansson M, Sawaji Y, Bolton M, et al: Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes. J Biol Chem 279: 43514-43521, 2004.
11. Kim JS, Ryoo ZY and Chun JS: Cytokine-like 1 (Cytl1) regulates the chondrogenesis of mesenchymal cells. J Biol Chem 282: 29359-29367, 2007.
12. Jeon J, Oh H, Lee G, et al: Cytokine-like 1 knock-out mice (Cytl1-/-) show normal cartilage and bone development but exhibit augmented osteoarthritic cartilage destruction. J Biol Chem 286: 27206-27213, 2011.
13. Chao C, Joyce-Shaikh B, Grein J, et al: C17 prevents inflammatory arthritis and associated joint destruction in mice. PLoS One 6: e22256, 2011.
14. Begley LA, Kasina S, MacDonald J and Macoska JA: The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine 43: 194-199, 2008.
15. Kwon YJ, Lee SJ, Koh JS, et al: Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol 7: 20-33, 2012.
16. Tomczak A and Pisabarro MT: Identification of CCR2-binding features in Cytl1 by a CCL2-like chemokine model. Proteins 79: 1277-1292, 2011.
17. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001.
18. Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006.
19. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002.
20. Pienta KJ and Loberg R: The 'emigration, migration, and immigration' of prostate cancer. Clin Prostate Cancer 4: 24-30, 2005.
21. Vicari AP and Caux C: Chemokines in cancer. Cytokine Growth Factor Rev 13: 143-154, 2002.
22. Gross N and Meier R: Chemokines in neuroectodermal cancers: the crucial growth signal from the soil. Semin Cancer Biol 19: 103-110, 2009.
23. Geminder H, Sagi-Assif O, Goldberg L, et al: A possible role for CXCR4 and its ligand, the CXC chemokine stromal cellderived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 167: 4747-4757, 2001.
24. Ara T and DeClerck YA: Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 25: 645-657, 2006.
25. Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002.
26. Zamore PD: RNA interference: listening to the sound of silence. Nat Struct Biol 8: 746-750, 2001.
27. Burnett JC, Rossi JJ and Tiemann K: Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol J 6: 1130-1146, 2011.
28. Patel R, T'Wallant N C, Herbert MH, White D, Murison JG and Reid G: The potency of siRNA-mediated growth inhibition following silencing of essential genes is dependent on siRNA design and varies with target sequence. Oligonucleotides 19: 317-328, 2009.
29. Suggate EL, Ahmed Z, Read ML, et al: Optimisation of siRNA-mediated RhoA silencing in neuronal cultures. Mol Cell Neurosci 40: 451-462, 2009.
30. Zhao M, Yang H, Jiang X, et al: Lipofectamine RNAiMAX: an efficient siRNA transfection reagent in human embryonic stem cells. Mol Biotechnol 40: 19-26, 2008.
31. Nabzdyk CS, Chun M, Pradhan L and Logerfo FW: High throughput RNAi assay optimization using adherent cell cytometry. J Transl Med 9: 48, 2011.